Chimeric Antigen Receptors Expand the Repertoire of Antigenic Macromolecules for Cellular Immunity

T-cell therapies have made significant improvements in cancer treatment over the last decade. One cellular therapy utilizing T-cells involves the use of a chimeric MHC-independent antigen-recognition receptor, typically referred to as a chimeric antigen receptor (CAR). CAR molecules, while mostly li...

Descripción completa

Detalles Bibliográficos
Autores principales: Keane, John T., Posey, Avery D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699116/
https://www.ncbi.nlm.nih.gov/pubmed/34943864
http://dx.doi.org/10.3390/cells10123356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699116/
https://www.ncbi.nlm.nih.gov/pubmed/34943864
http://dx.doi.org/10.3390/cells10123356

Ejemplares similares